Gilead Palo Alto, Inc.

Public Joint Stock Company “Sibur Holding”

Other

Gilead Sciences, Inc.

Open Joint Stock Company “Sibur Holding”

Timur Mikhailovich Zilbershtein

Jeff A Zablocki

Dmitry Koltun

Eric Q Parkhill

Natalya Vasilevich

Alexey Ivanov

Maxim Vladimirovich Lipskikh

Jeffrey Chisholm

Andrey Glushkov

Denis Alekseevich Lenev

Ian Henderson

Andrew Graham Cole

Vladislav Alexandrovich Kardash

Alexei Alexandrovich Nosikov

Georgy Viktorovich Nesyn

Andrei Glushkov

Vladlena Vladimirovna Suvorova

Tsung Lin

Methods of preparing oligomers of an olefin are provided. The methods can include providing an alkylaluminum compound and irradiating the alkylaluminum compound with microwave radiation to provide an irradiated alkylaluminum compound. The methods can further include mixing the irradiated alkylaluminum compound with a chromium compound, a pyrrole compound, and a zinc compound to provide a catalyst composition. The methods can further include contacting an olefin with the composition to form oligomers of the olefin. The olefin can include ethylene, and the oligomers of the olefin can include 1-hexene.

Methods of preparing oligomers of an olefin

Methods of preparing oligomers of an olefin are provided. The methods can include providing a composition that includes an alkylaluminum compound, a chromium compound, and a hydrocarbon solvent. The hydrocarbon solvent can include n-undecane, a C8-C11 alkane compound having one branch, or a mixture thereof. The methods can further include contacting an olefin with the composition to form oligomers of the olefin. The olefin can include ethylene, and the oligomers of the olefin can include 1-hexene.

A method of precipitating polymer and deactivated organometallic catalyst in an olefin oligomerization reaction is provided. The method includes providing an effluent stream from an olefin oligomerization reaction. The effluent stream can include a polymer and an organometallic catalyst. The method can further include introducing sorbent particles into the effluent stream. The sorbent particles can include a deactivating agent. The deactivating agent can be water, an alcohol, an amine, an amino alcohol, or a combination thereof. At least about 10% of the sorbent particles can have a particle size in a range from 10 &#x3bc;m and 60 &#x3bc;m. The method can further include cooling the effluent stream, thereby precipitating polymer and deactivated organometallic catalyst from the effluent stream to provide a precipitate that includes sorbent, polymer, and deactivated catalyst.

Methods of precipitating polymer and deactivated organometallic catalyst in an olefin oligomerization reaction

The invention relates to the production of olefin oligomers by a method of oligomerization of olefins, and, in particular, to a method of isolating olefin oligomerization products and decomposing the oligomerization catalyst residues. The method of isolating products of an oligomerization reaction of olefins including a terminal double bond, in which the reaction is carried out by the action of a catalyst having chromium compounds, a nitrogen-containing ligand and organoaluminum compounds, includes a step of isolating independent olefin products and a step of treating catalyst residues. Further, the method includes the following sequential steps:

Method for the isolation of olefin oligomerization products and the decomposition of oligomerization catalyst residues

The invention relates to the field of producing polymers and copolymers of olefin oligomers produced by a trimerization reaction of olefin monomers. There is disclosed a process which comprises producing olefin oligomers with the aid of a trimerization catalyst system prepared using UHF irradiation for activating individual components of the trimerization catalyst system. The use of the trimerization catalyst system thus improved and having increased activity provides for increased effectiveness in the production of olefin oligomers from ethylene or other olefin monomers, inter alia, at a low pressure of ethylene. The olefin oligomers thus produced are then polymerized or copolymerized using processes known in the art. The technical effect consists in increasing the effectiveness of the production of olefin oligomers which are then used in a polymerization or copolymerization reaction.

Catalyst system and processes for the (co-) trimerization of olefins and the (co-) polymerization of olefin oligomers

The present invention discloses 3,4-dihydroquinoxalin-2(1H)-ones for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

3, 4-dihydroquinoxalin-2(1H)-ones for use as stearoyl CoA desaturase inhibitors

The present invention discloses pyrido[2,3-B]pyrazinones having the structure of Formula I for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors

The present invention discloses pyrido[2,3-B]pyrazin-3(4h)-ones for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitors

The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I:  The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like.

Growing community of inventors

Kazan, Russia

Timur Mikhailovich Zilbershtein